Ezurpimtrostat

N/A

Report date: 2022/12/17 16:53:00
NME

Base Information

Drug NameEzurpimtrostat
Drug Alias NameGNS-561
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAutophagy inhibitorsApoptosis stimulantsPalmitoyl-protein thioesterase 1 inhibitors
TargetsPalmitoyl-protein thioesterase 1
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumoursHematologic Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPuerto Rico +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenoscience Pharma
China Registration ClassN/A

Develop Information

Active CompaniesGenfit CorpCentre Leon Berard
Inactive CompaniesGenoscience Pharma
Active IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumoursHematologic Neoplasms +[4] 
Inactive IndicationsLiver NeoplasmsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A